PoserCM, PatyDW, ScheinbergLNew diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol1983; 13: 227–31
2.
WhiteRF, ProctorSP.Solvents and neurotoxicity. Lancet1997; 349: 1239–43
3.
PoblanoA, Lope HuertaM, MartinezJM, FalconHD.Pattern-visual evoked potentials in thinner abusers. Arch Med Res1996; 27: 531–3
4.
YamanouchiN, OkadaS, KodamaKWhite matter changes caused by chronic solvent abuse. Ann J Neuroradiol1995; 16: 1643–9
5.
OrmerodIEC, MillerDH, McDonaldWIThe role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions: a quantitative study. Brain1987; 110: 1579–616
6.
TourtellotteWW, BaumhefnerRW, SyndulkoKThe long march of the cerebrospinal fluid profile indicative of clinical definite multiple sclerosis; and still marching. J Neuroimmunol1988; 20: 217–27